Webster Bank’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.6K | Sell |
278
-130
| -32% | -$6.88K | ﹤0.01% | 486 |
|
|
2026
Q1 | $22.5K | Buy |
408
+130
| +47% | +$7.04K | ﹤0.01% | 451 |
|
|
2025
Q4 | $13.6K | Hold |
278
| – | – | ﹤0.01% | 484 |
|
|
2025
Q3 | $12K | Hold |
278
| – | – | ﹤0.01% | 479 |
|
|
2025
Q2 | $10.7K | Hold |
278
| – | – | ﹤0.01% | 480 |
|
|
2025
Q1 | $10.8K | Hold |
278
| – | – | ﹤0.01% | 473 |
|
|
2024
Q4 | $9.4K | Hold |
278
| – | – | ﹤0.01% | 484 |
|
|
2024
Q3 | $11.4K | Hold |
278
| – | – | ﹤0.01% | 477 |
|
|
2024
Q2 | $10.7K | Hold |
278
| – | – | ﹤0.01% | 478 |
|
|
2024
Q1 | $11.9K | Hold |
278
| – | – | ﹤0.01% | 463 |
|
|
2023
Q4 | $10.3K | Hold |
278
| – | – | ﹤0.01% | 485 |
|
|
2023
Q3 | $10.1K | Hold |
278
| – | – | ﹤0.01% | 464 |
|
|
2023
Q2 | $9.91K | Hold |
278
| – | – | ﹤0.01% | 460 |
|
|
2023
Q1 | $9.89K | Hold |
278
| – | – | ﹤0.01% | 473 |
|
|
2022
Q4 | $10K | Buy |
+278
| New | +$9.26K | ﹤0.01% | 459 |
|
|
2022
Q3 | – | Sell |
-278
| Closed | -$15K | – | 537 |
|
|
2022
Q2 | $15K | Hold |
278
| – | – | ﹤0.01% | 431 |
|
|
2022
Q1 | $15K | Hold |
278
| – | – | ﹤0.01% | 450 |
|
|
2021
Q4 | $15K | Hold |
278
| – | – | ﹤0.01% | 459 |
|
|
2021
Q3 | $13K | Hold |
278
| – | – | ﹤0.01% | 457 |
|
|
2021
Q2 | $14K | Sell |
278
-276
| -50% | -$13.3K | ﹤0.01% | 436 |
|
|
2021
Q1 | $25K | Sell |
554
-332
| -37% | -$15.1K | ﹤0.01% | 391 |
|
|
2020
Q4 | $41K | Sell |
886
-1,907
| -68% | -$87.6K | ﹤0.01% | 343 |
|
|
2020
Q3 | $131K | Buy |
2,793
+607
| +28% | +$30.4K | 0.02% | 222 |
|
|
2020
Q2 | $111K | Buy |
2,186
+1,908
| +686% | +$97.9K | 0.02% | 218 |
|
|
2020
Q1 | $13K | Sell |
278
-860
| -76% | -$45.9K | ﹤0.01% | 386 |
|
|
2019
Q4 | $67K | Hold |
1,138
| – | – | 0.01% | 288 |
|
|
2019
Q3 | $61K | Hold |
1,138
| – | – | 0.01% | 293 |
|
|
2019
Q2 | $57K | Hold |
1,138
| – | – | 0.01% | 299 |
|
|
2019
Q1 | $59K | Sell |
1,138
-128
| -10% | -$6.4K | 0.01% | 288 |
|
|
2018
Q4 | $60K | Sell |
1,266
-43
| -3% | -$2.12K | 0.01% | 275 |
|
|
2018
Q3 | $66K | Sell |
1,309
-629
| -32% | -$32K | 0.01% | 300 |
|
|
2018
Q2 | $98K | Hold |
1,938
| – | – | 0.01% | 258 |
|
|
2018
Q1 | $95K | Hold |
1,938
| – | – | 0.01% | 269 |
|
|
2017
Q4 | $86K | Buy |
1,938
+800
| +70% | +$37K | 0.01% | 299 |
|
|
2017
Q3 | $58K | Buy |
1,138
+278
| +32% | +$14.1K | 0.01% | 340 |
|
|
2017
Q2 | $46K | Hold |
860
| – | – | 0.01% | 358 |
|
|
2017
Q1 | $45K | Hold |
860
| – | – | 0.01% | 375 |
|
|
2016
Q4 | $41K | Buy |
+860
| New | +$42.5K | 0.01% | 368 |
|
|
2016
Q3 | – | Sell |
-7,374
| Closed | -$399K | – | 219 |
|
|
2016
Q2 | $399K | Buy |
7,374
+592
| +9% | +$31.2K | 0.06% | 159 |
|
|
2016
Q1 | $344K | Hold |
6,782
| – | – | 0.05% | 170 |
|
|
2015
Q4 | $342K | Buy |
+6,782
| New | +$346K | 0.05% | 164 |
|
Other funds holding GSK
JEST
Webster Bank's GSK Position: Q2 2026 in Review
Webster Bank reduced its GSK (GSK) stake by 32% in Q2 2026, selling an estimated $6.88K and leaving 278 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #486.
Webster Bank first reported a position in GSK in Q4 2015 and has held it in 41 quarters since. The position peaked at $399K in Q2 2016. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Webster Bank held 278 shares of GSK worth $14.6K as of Q2 2026.
- Webster Bank sold 130 GSK shares in Q2 2026, an estimated $6.88K.
- GSK made up ﹤0.01% of Webster Bank's portfolio in Q2 2026, its #486 holding.
- Webster Bank first reported a position in GSK in Q4 2015 and has held it in 41 quarters since.
- Webster Bank's GSK position peaked at $399K in Q2 2016.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Webster Bank's 13F filing for Q2 2026, filed 20 Jul 2026.